BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26968827)

  • 1. Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.
    Arnesen MR; Rekstad BL; Stokke C; Bruheim K; Løndalen AM; Hellebust TP; Malinen E
    Radiat Oncol; 2016 Mar; 11():39. PubMed ID: 26968827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
    Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer.
    Sukhikh ES; Sukhikh LG; Lushnikova PA; Tatarchenko MA; Abdelrahman AR
    Phys Med; 2020 May; 73():83-88. PubMed ID: 32334401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET/CT guided in esophageal cancer.
    Zhang Y; Fan B; Sun T; Xu J; Yin Y; Chen Z; Zhu J; Yu J; Hu M
    J Cancer Res Ther; 2022 Sep; 18(5):1261-1267. PubMed ID: 36204871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
    Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
    Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
    Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
    Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
    Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
    Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
    Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer.
    Feng CH; Hasan Y; Kopec M; Al-Hallaq HA
    J Appl Clin Med Phys; 2016 Sep; 17(5):76-89. PubMed ID: 27685108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.
    Cheng JY; Huang EY; Hsu SN; Wang CJ
    Br J Radiol; 2016 Dec; 89(1068):20160526. PubMed ID: 27706947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional image-guided dose escalation in gliomas using of state-of-the-art photon vs. proton therapy.
    Holm AIS; Petersen JBB; Muren LP; Seiersen K; Borghammer P; Lukacova S
    Acta Oncol; 2017 Jun; 56(6):826-831. PubMed ID: 28464742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of bowel gas and body outline variations on total accumulated dose with intensity-modulated proton therapy in locally advanced cervical cancer patients.
    Berger T; Petersen JBB; Lindegaard JC; Fokdal LU; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1472-1478. PubMed ID: 28931343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
    Kato T; Ono T; Narita Y; Komori S; Murakami M
    Med Dosim; 2022 Autumn; 47(3):216-221. PubMed ID: 35346554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
    Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
    Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
    Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
    Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
    Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.
    Thureau S; Dubray B; Modzelewski R; Bohn P; Hapdey S; Vincent S; Anger E; Gensanne D; Pirault N; Pierrick G; Vera P
    Radiat Oncol; 2018 Oct; 13(1):208. PubMed ID: 30352608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
    Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.